Exane Derivatives’s Brunswick BC Stock Holding History

Exane Derivatives’s Portfolio BC Stock Details BC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-484	Closed	-$46.2K	–	1050
2021 Q1	$46.2K	Buy	+484	New	+$44.4K	0.01%	525

Other funds holding BC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

KCM

Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Exane Derivatives's BC Position: Q2 2021 in Review

Exane Derivatives sold out of Brunswick (BC) in Q2 2021, closing a stake of 484 shares — an estimated $46.2K sold.

Exane Derivatives first reported a position in BC in Q1 2021 and held it in 1 quarter. The position peaked at $46.2K in Q1 2021. 405 funds tracked by Wall St. Rank hold BC as of Q2 2021.

Exane Derivatives reported no remaining Brunswick position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 484 Brunswick shares in Q2 2021, an estimated $46.2K.
Exane Derivatives first reported a position in Brunswick in Q1 2021 and held it in 1 quarter.
Exane Derivatives's Brunswick position peaked at $46.2K in Q1 2021.
405 funds tracked by Wall St. Rank held Brunswick as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.